1st edition, October 9, 2012, Ramada Plaza, Europa Hall
Since 2009 the Romanian market, including the Pharma sector, has seen major changes. One of the biggest challenges the Pharmaceutical sector is facing is a shortage of specialists in an increasingly regulated environment. The labor market has seen a maturing of specialists and professionals due to the the pressures of the economic climate.
How to deal with the effects of the claw back tax? In August, the association of generic pharmaceuticals producers (AMPGR) voiced its opposition to the updated claw back mechanism and warned that hundred of cheap drugs would be withdrawn from the market. This is the fourth version of the tax that first came into force in 2009 and aims to control the consumption of innovative and generic drugs in Romania. However, producers argue that they are taxed for the whole distribution chain and that the claw back mechanism doesn’t reflect the real consumption from the previous year.